Similarly, there was remarkable expression of viral E1A protein (as an indicator of viral replication) in HCC cells treated with Ad-ΔB/TRAIL+ Ad-ΔB/IL-12 combination therapy than those treated with PBS-or Ad-ΔB (Fig. 2e). Here, DHTKD1 is linked to hepatocellular carcinoma.